HedgeChatter

  • Home /
  • Tag Archives

DRTX

Durata Therapeutics to Present at Upcoming Investor Conferences

[GlobeNewswire] – CHICAGO — Durata Therapeutics announced today that Paul R. Edick, CEO, will be presenting an overview of the Company at two upcoming investor conferences. moreView todays social media effects on DRTXView the latest stocks trending across Twitter. Click to view dashboardSee who Durata is hiring next, click here to view […]

May 9, 2014 Bystocknews , Comments Off on Durata Therapeutics to Present at Upcoming Investor Conferences read more

Durata Therapeutics Reports First Quarter 2014 Financial Results

[GlobeNewswire] – CHICAGO — Durata Therapeutics, Inc. today announced financial results for the quarter ended March 31, 2014. moreView todays social media effects on DRTXView the latest stocks trending across Twitter. Click to view dashboardSee who Durata is hiring next, click here to view […]

May 8, 2014 Bystocknews , Comments Off on Durata Therapeutics Reports First Quarter 2014 Financial Results read more

5:11 pm Durata Therapeutics confirms FDA Advisory Committee unanimously recommends approval of Dalvance for the treatment of acute bacterial skin and skin structure infections (stock halted)

moreView todays social media effects on DRTXView the latest stocks trending across Twitter. Click to view dashboardSee who Durata is hiring next, click here to view […]

April 1, 2014 Bystocknews , Comments Off on 5:11 pm Durata Therapeutics confirms FDA Advisory Committee unanimously recommends approval of Dalvance for the treatment of acute bacterial skin and skin structure infections (stock halted) read more

FDA Advisory Committee Unanimously Recommends Approval of Dalvance(TM) for the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

[GlobeNewswire] – CHICAGO — Durata Therapeutics, Inc. announced today that the U.S. Food and Drug Administration’s (FDA) Anti-Infective Drugs Advisory Committee voted 12 to 0 that the Company has provided substantial evidence … moreView todays social media effects on DRTXView the latest stocks trending across Twitter. Click to view dashboardSee who Durata is hiring next, click here to view […]

March 31, 2014 Bystocknews , Comments Off on FDA Advisory Committee Unanimously Recommends Approval of Dalvance(TM) for the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) read more

[$$] How a Giant Kazakh Oil Project Went Awry

[at The Wall Street Journal] – Blucora is preparing to challenge Spencer Sprit Holdings with an all-cash bid for Brookstone. moreView todays social media effects on DRTXView the latest stocks trending across Twitter. Click to view dashboardSee who Durata is hiring next, click here to view […]

March 31, 2014 Bystocknews , Comments Off on [$$] How a Giant Kazakh Oil Project Went Awry read more